Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is now the most common progressive liver disease in developed countries and is the second leading indication for liver transplantation due to the extensive fibrosis it causes. NAFLD progression is thought to be tied to chronic low-level type 1 inflammation originating in the adipose tissue during obesity; however, the specific immunological mechanisms regulating the progression of NAFLD-associated fibrosis in the liver are unclear. To investigate the immunopathogenesis of NAFLD more completely, we investigated adipose dysfunction, nonalcoholic steatohepatitis (NASH), and fibrosis in mice that develop polarized type 1 or type 2 immune responses. Unexpectedly, obese interleukin-10 (IL-10)/IL-4-deficient mice (type 1-polarized) were highly resistant to NASH. This protection was associated with an increased hepatic interferon-γ (IFN-γ) signature. Conversely, IFN-γ-deficient mice progressed rapidly to NASH with evidence of fibrosis dependent on transforming growth factor-β (TGF-β) and IL-13 signaling. Unlike increasing type 1 inflammation and the marked loss of eosinophils seen in expanding adipose tissue, progression of NASH was associated with increasing eosinophilic type 2 liver inflammation in mice and human patient biopsies. Finally, simultaneous inhibition of TGF-β and IL-13 signaling attenuated the fibrotic machinery more completely than TGF-β alone in NAFLD-associated fibrosis. Thus, although type 2 immunity maintains healthy metabolic signaling in adipose tissues, it exacerbates the progression of NAFLD collaboratively with TGF-β in the liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [146]
Citations
Cites
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Lebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationEosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis
Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A., & Locksley, R. M. (2011) · Science · doi:10.1126/science.1201475 · Cited by 1,376
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
Eosinophils: changing perspectives in health and disease
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3341 · Cited by 989
Molofsky, A. B., Nussbaum, J. C., Liang, H.-E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A., & Locksley, R. M. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121964 · Cited by 874
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847
Protection from obesity and diabetes by blockade of TGF-β/smad3 signaling
Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.013 · Cited by 709
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615
Self-citationRot, A., Krieger, M., Brunner, T., Bischoff, S. C., Schall, T. J., & Dahinden, C. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1489 · Cited by 611
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
Innate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
Hoffmann, K. F., Cheever, A. W., & Wynn, T. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6406 · Cited by 473
Self-citationPeriostin promotes chronic allergic inflammation in response to Th2 cytokines
Masuoka, M., Shiraishi, H., Ohta, S., Suzuki, S., Arima, K., Aoki, S., Toda, S., Inagaki, N., Kurihara, Y., Hayashida, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58978 · Cited by 388
Eosinophils secrete IL-4 to facilitate liver regeneration
Goh, Y. P. S., Henderson, N. C., Heredia, J. E., Red Eagle, A., Odegaard, J. I., Lehwald, N., Nguyen, K. D., Sheppard, D., Mukundan, L., Locksley, R. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304046110 · Cited by 277
Yang, L., Roh, Y. S., Song, J., Zhang, B., Liu, C., Loomba, R., & Seki, E. (2014) · Hepatology · doi:10.1002/hep.26698 · Cited by 275 · cited 2×
“Although a previous study characterized hepatocyte-specific deletion of Tgfbr2 in choline-deficient diet-induced NASH (45), our studies represent experimental intervention of TGF-b focusing on two critical targets of TGF-b signaling, fibroblasts and immune cells, without the caveat of eliminating potentially important…”
BackgroundLongitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 253
IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity
Ricardo-Gonzalez, R. R., Red Eagle, A., Odegaard, J. I., Jouihan, H., Morel, C. R., Heredia, J. E., Mukundan, L., Wu, D., Locksley, R. M., & Chawla, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009152108 · Cited by 252
Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases
Schmid-Grendelmeier, P., Altznauer, F., Fischer, B., Bizer, C., Straumann, A., Menz, G., Blaser, K., Wüthrich, B., & Simon, H.-U. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1021 · Cited by 234
Hall, M.-C., Young, D. A., Waters, J. G., Rowan, A. D., Chantry, A., Edwards, D. R., & Clark, I. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212334200 · Cited by 232
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3977-1 · Cited by 218
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Reiman, R. M., Thompson, R. W., Feng, C. G., Hari, D., Knight, R., Cheever, A. W., Rosenberg, H. F., & Wynn, T. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1471-1479.2006 · Cited by 206
Self-citationInterleukin-10 is a protective factor against diet-induced insulin resistance in liver
Cintra, D. E., Pauli, J. R., Araújo, E. P., Moraes, J. C., de Souza, C. T., Milanski, M., Morari, J., Gambero, A., Saad, M. J., & Velloso, L. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.017 · Cited by 182
Nonalcoholic steatohepatitis: a search for factual animal models
Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S. (2015) · BioMed Research International · doi:10.1155/2015/574832 · Cited by 174
Lake, A. D., Novak, P., Fisher, C. D., Jackson, J. P., Hardwick, R. N., Billheimer, D. D., Klimecki, W. T., & Cherrington, N. J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040592 · Cited by 167
Miller, A. M., Wang, H., Bertola, A., Park, O., Horiguchi, N., Ki, S. H., Yin, S., Lafdil, F., & Gao, B. (2011) · Hepatology · doi:10.1002/hep.24517 · Cited by 162
Stärkel, P., Sempoux, C. L., Leclercq, I. A., Hérin, M., Deby, C. M. T., Desager, J., & Horsmans, Y. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00360-x · Cited by 146
Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet
Tan, C. K., Leuenberger, N., Tan, M. J., Yan, Y. W., Chen, Y., Kambadur, R., Wahli, W., & Tan, N. S. (2011) · Diabetes · doi:10.2337/db10-0801 · Cited by 146
BJÖRNSSON, E., KALAITZAKIS, E., & OLSSON, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03330.x · Cited by 137
Hoffmann, K. F., James, S. L., Cheever, A. W., & Wynn, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.927 · Cited by 132
Self-citationGieseck, R. L., Ramalingam, T. R., Hart, K. M., Vannella, K. M., Cantu, D. A., Lu, W.-Y., Ferreira-González, S., Forbes, S. J., Vallier, L., & Wynn, T. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.009 · Cited by 132
Self-citationLipoatrophic diabetes in Irs1−/−/Irs3−/− double knockout mice
Laustsen, P. G., Michael, M. D., Crute, B. E., Cohen, S. E., Ueki, K., Kulkarni, R. N., Keller, S. R., Lienhard, G. E., & Kahn, C. R. (2002) · Genes & Development · doi:10.1101/gad.1034802 · Cited by 131
Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps
Poposki, J. A., Uzzaman, A., Nagarkar, D. R., Chustz, R. T., Peters, A. T., Suh, L. A., Carter, R., Norton, J., Harris, K. E., Grammer, L. C., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.017 · Cited by 121
Kwak, H., Park, M., Cho, H., Park, C.-M., Moon, S., Lee, H.-C., Park, I., Kim, M.-S., Rhee, C. H., & Hong, S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0140 · Cited by 120
Triglyceride measurements: a review of methods and interferences
Klotzsch, S. G., & McNamara, J. R. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.9.1605 · Cited by 115
Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities
Shaker, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5320 · Cited by 112
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung
Venge, J., Lampinen, M., Håkansson, L., Rak, S., & Venge, P. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70265-8 · Cited by 110
Paredes-Turrubiarte, G., González-Chávez, A., Pérez-Tamayo, R., Salazar-Vázquez, B. Y., Hernández, V. S., Garibay-Nieto, N., Fragoso, J. M., & Escobedo, G. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0347-4 · Cited by 90
den Boer, M. A. M., Voshol, P. J., Schröder-van der Elst, J. P., Korsheninnikova, E., Ouwens, D. M., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2006) · Endocrinology · doi:10.1210/en.2006-0417 · Cited by 85
TGF-β1 and FAK Regulate Periostin Expression in PDL Fibroblasts
Wen, W., Chau, E., Jackson‐Boeters, L., Elliott, C. G., Daley, T. D., & Hamilton, D. W. (2010) · Journal of Dental Research · doi:10.1177/0022034510378684 · Cited by 79
Non-alcoholic fatty liver disease in 2016
Townsend, S. A., & Newsome, P. N. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw031 · Cited by 74
Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea
Emery, D. L., Djokic, T. D., Graf, P. D., & Nadel, J. A. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.67.3.959 · Cited by 73
Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice
Proctor, W. R., Chakraborty, M., Chea, L. S., Morrison, J. C., Berkson, J. D., Semple, K., Bourdi, M., & Pohl, L. R. (2013) · Hepatology · doi:10.1002/hep.26196 · Cited by 52
Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
Calcaterra, V., AMICI, M. D., Klersy, C., Torre, C., Brizzi, V., Scaglia, F., Albanesi, M., Albertini, R., Allais, B., & Larizza, D. (2009) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 50
Cayón, A., Crespo, J., Mayorga, M., Guerra, A., & Pons‐Romero, F. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01337.x · Cited by 45
Zahran, W. E., El-Dien, K. A. S., Kamel, P. G., & El-Sawaby, A. S. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0236-5 · Cited by 44
Measurement of Liver Triglyceride Content
Jouihan, H. (2012) · BIO-PROTOCOL · doi:10.21769/bioprotoc.223 · Cited by 40
Zhang, S., Wu, X., & Yu, S. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12118 · Cited by 31
Endothelin-1 peptides and IL-5 synergistically increase the expression of IL-13 in eosinophils
Cui, P., Sharmin, S., Okumura, Y., Yamada, H., Yano, M., Mizuno, D., & Kido, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.168 · Cited by 13
Fujishima, H., Fukagawa, K., Okada, N., Takano, Y., Hirai, H., Nagata, K., Hashida, R., Matsumoto, K., & Saito, H. (2013) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.05.027 · Cited by 11
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationType 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Self-citationThe role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 359
Metadata
- Authors
- Hart, K. M., Fabre, T., Sciurba, J. C., Gieseck, R. L., Borthwick, L. A., Vannella, K. M., Acciani, T. H., de Queiroz Prado, R., Thompson, R. W., White, S., Soucy, G., Bilodeau, M., Ramalingam, T. R., Arron, J. R., Shoukry, N. H., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- Newcastle University (GB)
- Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada.
- Genentech (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-06-28
- Volume
- 9
- Issue
- 396
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2724672633
- Cited by
- 143
- References
- 55
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 15 · 2023: 16 · 2022: 17 · 2021: 13 · 2020: 19 · 2019: 16 · 2018: 14 · 2017: 6
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- NIH Office of the Director (award305255)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, Th2 immune response, TGF-beta, IL-13, liver fibrosis, nonalcoholic steatohepatitis, interferon-gamma, eosinophils, adipose tissue dysfunction, obesity, immunopathogenesis, metabolic disorders
- MeSH terms
- Adipose Tissue, Animals, Eosinophils, Humans, Immunity, Inflammation, Interferon-gamma, Liver Cirrhosis, Male, Metabolic Diseases, Mice, Inbred C57BL, Obesity, Transforming Growth Factor beta, Disease Progression, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.